Synthesis and Antiproliferative Activity of [RuCp(PPh3)2(HdmoPTA)](OSO2CF3)2 (HdmoPTA = 3,7-H-3,7-Dimethyl-1,3,7-triaza-5-phosphabicyclo[3.3.1]nonane) | Zendy

Zenaida Mendoza | Zendy; Pablo LorenzoLuis | Zendy; Manuel SerranoRuiz | Zendy; Elva Martín-Batista | Zendy; José M. Padrón | Zendy; Franco Scalambra | Zendy; Antonio Romerosa | Zendy

Open Access

Synthesis and Antiproliferative Activity of [RuCp(PPh₃)₂(HdmoPTA)](OSO₂CF₃)₂ (HdmoPTA = 3,7-H-3,7-Dimethyl-1,3,7-triaza-5-phosphabicyclo[3.3.1]nonane)

Author(s) -

Zenaida Mendoza,

Pablo LorenzoLuis,

Manuel SerranoRuiz,

Elva Martín-Batista,

José M. Padrón,

Franco Scalambra,

Antonio Romerosa

Publication year - 2016

Publication title -

inorganic chemistry

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.348

H-Index - 233

eISSN - 1520-510X

pISSN - 0020-1669

DOI - 10.1021/acs.inorgchem.6b01207

Subject(s) - chemistry , nonane , crystal structure , stereochemistry , crystallography , x ray crystallography , single crystal , diffraction , physics , optics

The complex [RuCp(PPh3)2(HdmoPTA)](OSO2CF3)2 (2; HdmoPTA = 3,7-H-3,7-dimethyl-1,3,7-triaza-5-phosphabicyclo[3.3.1]nonane) was synthesized and characterized. Its crystal structure was determined by single-crystal X-ray diffraction. The complex showed a more potent antiproliferative activity than cisplatin against a representative panel of human cancer cells.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research